When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OMER - Omeros' narsoplimab successful in pivotal HSCT-TMA study; shares up 4% premarket
Omeros Corporation
Omeros (NASDAQ:OMER) is up 4% premarket on light volume in response to positive data from a pivotal Phase 2 clinical trial evaluating narsoplimab (OMS721) for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (blood clots in tiny blood vessels) (HSCT-TMA), a frequently lethal complication of HSCT.
More news on: Omeros Corporation, Healthcare stocks news, Stocks on the move,